milestone payments Genuity Science, Ionis Pharmaceuticals Partner on Antisense Therapy Development Genuity Science, formerly known as WuXi NextCode, will receive a combination of upfront, development milestone, and product royalty payments under the deal. Amgen, Adaptive Biotechnologies Expand Partnership on NGS Blood Cancer Monitoring The partners will use Adaptive's ClonoSeq assay to assess minimal residual disease in several of Amgen's hematology drug development programs. Tempus, Genmab Collaborate on Cancer Biomarker Discovery Tempus is eligible for milestone payments and royalties for any oncology therapeutics Genmab might develop based on their joint research projects. Interpace Dx Reaches Deal to Restructure Debt As part of the deal with an institutional investor, Interpace's royalty and milestone obligations will also be terminated. Stratos Hits Milestone, Raises $15M from Roche, Fisk Ventures to Complete Series B Financing Stratos reached its milestone by demonstrating nanopore sequencing with its proprietary expandable nucleotides, called X-NTPs. Dec 5, 2013 Alnylam Receives $7M Milestone from Genzyme Premium Oct 25, 2012 Isis to Receive $1.1M from Alnylam Premium Aug 2, 2012 Alnylam Receives $3.2M Milestone from GSK Under Vaccine Collaboration Premium Dec 15, 2011 Dicerna Earns $5M Milestone as Partner Kyowa Picks up Cancer Drug Premium Jul 21, 2011 Regulus IDs miRNA Target in GSK Collaboration Premium Jan 7, 2010 Alnylam Receives Undisclosed Milestone from Roche Under RNAi Rx Collaboration Premium Breaking News DNAe, Imperial College London, U of Leicester to Develop NGS-Based Breast Cancer Monitoring Test Illumina, Israel Ministry of Health to Pilot Genome Sequencing for Diagnosing Critically Ill Infants GenomSys Gains CE Mark for New Genomic Analysis Software Thermo Fisher Scientific Q3 Revenues up 9 Percent BTIG Initiates Coverage of LumiraDx With Buy Rating Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms The Scan Panel Recommends Pfizer-BioNTech Vaccine for Kids CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old. Sharing How to Make It Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times. Bring it Back In Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray. Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.